Introduction
There are numerous cases in the cell in which gene expression is controlled by regulated nuclear transport. Because transcription and translation take place in the nucleus and cytoplasm, respectively, the cell is able to control each process by what it makes available in each compartment. For example, a number of constitutively nuclear proteins are required to maintain nuclear structure and function and many of these must be imported into the nucleus after their translation in the cytoplasm. Conversely, RNAs of all types must be transported out of the nucleus to partake in translation, and this export appears to be dependent on proteins bound to that RNA (proteins that must first be imported). In addition, nuclear transport can also be utilized to control the timing of gene expression by regulating the transport of proteins that stimulate (or inhibit) transcription of a particular gene or set of genes. Since a protein (or protein fragment) cannot directly activate transcription on chromatin until it physically binds it, keeping it out of the nucleus keeps it away from chromatin. So, to put it simply, as long as the potential transcription factor is kept out of the nucleus it can't act as a transcription factor.
The nuclear and cytoplasmic compartments of the eukaryotic cell are separated by the nuclear envelope, and the only means of passage between these two compartments is through the nuclear pore complexes (NPCs). The NPCs allow diffusion of molecules smaller than approx. 50 kDa between the compartments, but larger molecules must be transported actively. The presence of a nuclear localization sequence (NLS) on a protein can result in transport of that protein into the nucleus. The classical or basic type of NLS is generally comprised of either a short stretch of basic amino acids or two short stretches separated by a spacer region of about 10 amino acids (bipartite NLS). While this type of NLS was the first one to be discovered, there now appear to be several different kinds of sequence (each with their own receptor) that can function as NLSs. Conversely, a nuclear export sequence (NES) causes export of proteins from the nucleus to the cytoplasm. One type is rich in hydrophobic amino acids (particularly leucine) but like NLSs, there are now known to be multiple forms of NES (see Chapter 8 in this volume by Barry and Wente). However, the mere presence of these signals is not always sufficient to result in directional transport of the protein. The signal must be exposed in the correct conformation so as to be accessible to the transport machinery. The activity of these signals can be modified (either positively or negatively) by various modifications in the protein structure. In this manner, the cell can regulate the localization of proteins by manipulating their modifications. In this chapter we will describe the effects of three different types of structural modification that are known to affect nuclear transport: ligand binding, phosphorylation and proteolysis.
Ligand-mediated nuclear import
In some cases the cellular localization of an NLS-containing protein is controlled by ligand binding by that protein, an example being the glucocorticoid receptor (GR). Glucocorticoids are steroid hormones produced during starvation conditions that have metabolic effects on several cell types. Immunofluorescence microscopy shows that in the absence of glucocorticoid (or dexamethasone, a glucocorticoid agonist) most of the GR is located in the cytoplasm, but migrates into the nucleus when dexamethasone is added (see Figure 1 ). This migration into the nucleus is rapid, with a t 1/2 of approx. 5 min following the addition of dexamethasone. How does the addition of ligand affect the nuclear transport of the GR receptor?
The GR receptor contains two NLSs encoded in the protein, designated NL1 and NL2 [1] . While there are rough consensus sequences for some NLS motifs, the ultimate proof of a region's activity is to attach the putative NLS to a cytoplasmic reporter protein and determine whether the presence of that putative NLS confers nuclear import on the reporter. NL1, the more N-terminal NLS similar to the bipartite NLS consensus sequence, is near the DNAbinding domain of the GR. Fusion of this part of the GR (amino acid residues 497-524) with ␤-galactosidase, a protein not normally imported into the nucleus, confers nuclear import upon it regardless of the presence or absence of dexamethasone. This ligand-independent nuclear import is probably more typical of NLS-containing proteins than the ligand-dependent form. The GR is now known to contain both types.
There is a second NLS (NL2) in a region of the GR within the ligandbinding domain (amino acids 540-795) [1] . Fusion of this region of the GR with ␤-galactosidase confers nuclear localization of the reporter only when dexamethasone is added. The presence of these two NLSs on the protein, one constitutive and the other regulated, would presumably result in constitutive nuclear localization of the GR. Why then does GR appear cytoplasmic in cells to which ligand has not been added? It has been determined recently that the GR also contains a NES [2] , which stimulates export of proteins from the nucleus. The presence of both an NES and an NLS on the same protein results in shuttling, in which the protein moves constantly between the two compartments. In the absence of ligand only the constitutive NL1 is active, and by immunofluorescence microscopy the GR appears cytoplasmic. In this case nuclear export of ligand-free GR directed by the NES is more rapid than the rate of import stimulated by NL1. The fact that the GR is shuttling can be demonstrated by the addition of leptomycin B, an inhibitor of certain types of nuclear export. In the absence of ligand, addition of leptomycin B increases the amount of GR localization in the nucleus, indicating that maintenance of the high levels of GR in the cytoplasm in the absence of ligand is dependent on nuclear export. Thus the changes in steady-state GR localization in the presence and absence of ligand are probably due to a change in the relative rates of import and export ( Figure 2 ). In effect, while the single NES is more efficient 
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ϩ Dexamethasone than NL1 alone, the NES is less efficient at inducing export than the combined effects of NL1 and NL2 at inducing import in the presence of ligand. Shuttling may allow low-level constitutive expression in the absence of hormone, but be able to respond quickly to a rise in hormone levels by increasing the proportion of nuclear receptor.
There are a number of ways in which ligand binding could differentially affect the rates of import versus export. Ligand binding could affect the exposure or conformation of NL2 or the NES directly. Alternatively, ligand binding to GR could affect its affinity for a number of proteins, such as import or export factors (for example, karyopherin ␣ or CRM1, see Chapter 7 in this volume by Rout and Aitchison). Changes in these affinities could also affect the rates of nuclear transport. In any case, the net effect of the addition of ligand is a dynamic change in the cellular localization of GR, and consequently the expression of genes controlled by this transcription factor.
Effects of phosphorylation on nuclear import
Proteins can also be covalently modified by cellular enzymes, and this modification can affect their activity. One very common post-translational modification is phosphorylation. In some cases changing the phosphorylation state of a protein can also change its cellular location. SWI5 is an example of such a protein. SWI5 is a transcription factor in yeast that stimulates 108 Essays in Biochemistry volume 36 2000
Figure 2. The GR shuttles between the nuclear and cytoplasmic compartments
In the absence of ligand, nuclear export is more efficient than nuclear import. However, in the presence of ligand (dexamethasone, Dex), the nuclear-import reaction is favoured, and the nuclear concentration of Dex-GR increases. In the nucleus, the Dex-GR is capable of binding to DNA and initiating transcription of genes containing glucocorticoid-responsive elements (GREs) Fusion of amino acids 633-682 of SWI5 to ␤-galactosidase confers cellcycle-specific nuclear localization identical to that seen in the wild-type protein [3] . Sequence analysis of this region identified not only a bipartite NLS, but also two potential phosphorylation sites at Ser-646 and Ser-664, with a third reasonably close by at Ser-522 [4] . This raised the possibility that phosphorylation at one or more of these sites could affect the nuclear transport of the SWI5 transcription factor. Phosphorylation of specific residues can be determined by labelling cells with 32 P, isolating the protein of interest and producing peptides of that protein by digesting it with a protease such as trypsin. These peptides are separated by electrophoresis, and the presence of 32 P on specific peptides examined. Using such analysis on cells from different stages of the cell cycle, it was determined that all three serine residues were phosphorylated during the M (when the protein stays in the cytoplasm), but not during the G 1 (when SWI5 enters the nucleus), phase. The proximity of the phosphoserines to the NLS lends credence to this hypothesis that phosphorylation of SWI5 could inhibit its nuclear localization. This idea was supported by experiments in which one or more of the serine residues were mutated to alanine, which cannot be phosphorylated. Mutation of all three serines resulted in constitutive nuclear localization of SWI5, and its localization was most sensitive to mutation of Ser-646, which is in the midst of the bipartite NLS. Thus the ability of SWI5 to be imported into the nucleus correlates well with dephosphorylation of the cytoplasmic protein (Figure 3 ).
There are also examples of proteins in which phosphorylation can stimulate nuclear import [5] . In some cases the mechanism of this effect has been determined. For example, phosphorylation of protein kinase C-␣ stimulates nuclear import by inducing conformational changes that unmask its NLS. Phosphorylation or dephosphorylation of a protein can also stimulate the formation (or disassembly) of a protein complex. For example, nuclear localization of the Dorsal protein in Drosophila melanogaster is stimulated when phosphorylation induces its release from the Cactus protein in the cytoplasm. There are many examples of the nuclear transport of a protein being regulated by its phosphorylation state, and depending on the protein this modification can either stimulate or inhibit its nuclear import or export. In summary, phos-phorylation appears to play a critical role in regulating nuclear transport in a vast number of cellular processes from T-cell activation to the establishment and maintenance of circadian rhythm.
Regulation of nuclear transport by proteolysis
Perhaps the simplest way of regulating a protein's intracellular movement is by physically tethering the protein and then releasing it in response to a signal so that it is free to move. In two different examples that we will look at, the cell accomplishes this by activating specific proteases in response to specific signals. These proteases cut off the cytoplasmic domains of selected transmembrane proteins which are then free to enter the nucleus and subsequently activate transcription.
The first example of this type of regulation was discovered in a family of proteins that play an essential role in the control of cholesterol homoeostasis in animal cells, the family of transmembrane transcription factors called sterol regulatory-element-binding proteins (SREBPs; reviewed in [6] ). Investigators had known for a number of years that in response to cholesterol depletion, the rate of transcription of mRNAs coding for two key proteins involved in cholesterol metabolism was greatly increased. The amounts of both the low-density lipoprotein receptor (which binds and internalizes cholesterol from the bloodstream into the cell) and 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase (the rate-limiting enzyme in cholesterol biosynthesis) were greatly increased when cholesterol dropped below a certain level in animal cells. There had to be a transcription factor (or factors) activated in response to cholesterol depletion, but it eluded purification and identification until 1993 when the first 
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Transcription of HO gene member of the SREBP family was finally identified. It was immediately apparent from its cDNA sequence and cellular location why this protein had been so difficult to purify. Investigators had been trying to isolate a soluble cellular protein only to find that the elusive SREBPs are in fact transmembrane proteins normally found anchored in membranes of the endoplasmic reticulum and nuclear envelope. These proteins are oriented such that the region of the protein that possesses transcriptional activity faces the cytoplasm. Under conditions of cholesterol (sterol) depletion, these proteins undergo a series of activated proteolytic cleavages that cut the transcriptionally active fragment away from the portion of the protein that remains membrane-bound. This fragment then enters the nucleus and turns on transcription of its target genes ( Figure 4) . Proof that the transcriptional activity of the SREBP family members is regulated by their proteolysis came when cells were transfected with truncated SREBP proteins lacking their transmembrane domains. These truncated SREBPs did not require proteolysis in order for them to enter the nucleus and activate transcription. As would be predicted by the model outlined here, these transfected cells were no longer responsive to their internal cholesterol levels and as a result their SREBP-responsive genes were continuously activated, resulting in an enormous build up of cholesterol within the cell. Another example where the nuclear import of a protein is regulated by its proteolysis is found in the Notch receptor family (reviewed in [7] ). This family of receptors plays numerous critical roles in the determination of cell fate during the development of a number of organisms. These receptors operate in a signalling cascade that has three parts: (i) the ligands for these receptors, the so-called DSL ligands (for Delta, Serrate, Lag-2), whose binding activates the Notch receptors, (ii) the Notch receptors themselves and (iii) the downstream effector of these receptors, the so-called CSL transcription factor [for CBF1, What is not clear at present is where in the cell the binding of the Notchreceptor fragment and the CSL transcription factor occurs; whether the CSL protein is normally nuclear and is joined there by the cleaved Notch receptor fragment or whether these two join in the cytoplasm and translocate into the nucleus together. Also unknown is whether there are specific nuclear-transport signals that become functional upon proteolysis (in either example) or whether the nuclear translocation observed is dependent solely on the reduced size of the protein fragment. In either case, it appears that the nuclear translocation of the SREBP and Notch-receptor proteins and their subsequent transcriptional activity is regulated directly by the activated proteolysis of a membrane-bound protein.
In summary, modulation of nuclear localization provides an elegant method for regulating gene expression. In this manner it is possible to transcribe and translate a pool of transcription factor, but maintain it in a state in which it is functionally inactive by keeping it in the cytoplasm. In response to the proper signal the protein is modified, affecting its nuclear transport and ultimately its transcriptional activity. This provides a very rapid method of gene-expression control that is not dependent on intervening transcriptional/translational steps. Instances of this type of regulated import and export are being discovered daily, and it is becoming increasingly clear that regulated nuclear transport is an important method of controlling gene expression. The cell uses this method of regulating gene expression over and over again in control of the cell cycle, cell signalling and development. Only the eukaryotic cell, with its nuclear envelope separating the nucleus and the cytoplasm, is capable of nuclear transport, as the prokaryotic cell does not contain a nucleus. This ability of the eukaryotic cell to carry out nuclear transport may well explain why this cell type is capable of more complicated behaviour, a capability that was necessary for the development of multicellular organisms. 
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